It frequently takes the mainstream media a bit of time to catch up with the newest medical research findings but it appears studies warning of links between low testosterone therapy and heart attacks have begun showing up on their radar.
The Orlando Sentinel, a major Florida newspaper, recently profiled the dangers of Low-T treatments and how some pharmaceutical companies and doctors may be putting profits above concerns about patient safety.
The reports are interesting and perhaps vital information for men who have been treated with such FDA-approved medications as AndroGel, Androderm, Axirom, Bio-T-Gel, Delatestry, Depo-Testosterone, Fortesta, Striant, Testim and Testopel.
They are also a bit ironic, in that those medications are frequently marketed through prominent advertisements in newspapers and on radio and television.
As the Orlando Sentinel report said:
”What man could resist the promises made by clinics offering to cure him of his low testosterone? But as with most anti-aging elixirs, low T therapy may not be all that is promised. Nor is it for every man looking to boost virility, said Dr. Joe Littlejohn, a urologist at Orlando Health.
“While men’s health experts agree that low T, also called hypogonadism, is a real problem for some, they agree less on which men should be treated, and to what extent. ‘There is definitely some controversy,’ said Littlejohn, who worries about the harmful effects of overtreatment.
“Some also worry that low T clinics, which are sprouting up by the dozens throughout the region, are converting men’s insecurity into profits. Read more about testosterone class action lawsuit.
“Only about 5.6 percent of men have low T with symptoms, which include low energy, less interest in sex, weight gain and trouble concentrating, according to a study published in The Journal of Clinical Endocrinology and Metabolism.”
The Orlando Sentinel report comes just months after at least two respected medical research studies have raised red flags over concerns that Low-T therapy medications being used by millions of men may put these men at serious risk of suffering a stroke or heart attack.
In addition, the Food and Drug Administration issued a national Drug Safety Communication in which officials said they are “investigating the risk of stroke, heart attack, and death in men taking FDA-approved testosterone products.”